Rein in Sarcoma proudly announces a $150,000 research grant approved by the Rein in Sarcoma Board on January 27, 2020. This brings the cumulative research funding by Rein in Sarcoma to $2 million since the organization’s founding in 2001. This grant will fund the following three exciting University of Minnesota Masonic Cancer Center projects: “eBAT…
Rein in Sarcoma has awarded $45,000 in new sarcoma research grants to Children’s Minnesota and the Mayo Clinic. Children’s Minnesota “Expanding Opportunities For Early Detection of Sarcoma.” | $20,000 Co-Principal Investigators: Megan Hilgers, MD, pediatric oncologist and Kris Ann P. Schultz, MD, pediatric oncologist. Lay Summary: Liquid biopsies are a promising technique to facilitate tumor…
By Miranda Mead Beau Webber, a 2018 RIS research grant recipient, is an Assistant Professor, Department of Pediatrics at the University of Minnesota, as well as Faculty Member of the Division of Pediatric Hematology and Oncology and Stem Cell Institute. While getting his PhD in stem-cell biology and genetic engineering at the University of Minnesota,…
Funding sarcoma research is one prong of Rein in Sarcoma’s three-pronged mission. With the great support of donors including a significant gift through the Hallie Anne Brown Named Fund, physicians, researchers, and board members RIS expanded research funding in 2017. This expansion not only grew our commitment to the University of Minnesota, but provided research…
On May 2019, Mayo Clinic oncologist and RIS Medical Advisory Board Member, Dr. Steven Robinson, hosted a meeting for Mayo colleagues to learn about Rein in Sarcoma’s initiatives. Over lunch provided by the Red Flags Committee, Mayo Radiation Oncologist and RIS Medical Advisory Board Member Safia Ahmed, presented the new Rein in Sarcoma Patient Starter…
Rein in Sarcoma proudly announces a $150,000 research grant approved by the Rein in Sarcoma Board in January, 2019. This grant will fund the following three exciting University of Minnesota Masonic Cancer Center projects: “MYOG Promoter-Controlled Oncolytic Adenovirus to Treat PAX3-FOXO1-Positive Rhabdomyosarcoma” | $50,000 Principle Investigator: Masato Yamamoto, MD, PhD Co-Investigator: H Yoshida, MD, PhD…
Rein in Sarcoma announced significant new research grants totaling $65,000 at our recent Fall Fundraiser. For the second year, RIS awarded grants to researchers at Mayo Clinic and Children’s Hospitals and Clinics of Minnesota. We also announced multi-year support for a SARC SPORE grant proposal. The evening included a new commitment to increase sarcoma research…
“Predicting relapse and response to chemotherapy in sarcoma.” | $49,000 Principal Investigator: Amy Skubitz, PhD – Professor of Laboratory Medicine and Pathology, Professor of Obstetrics, Gynecology and Women’s Health, University of Minnesota Summary: Predicting the behavior of a sarcoma tumor in a patient is of critical importance in their care. When a primary tumor is…
Rein in Sarcoma Board member and Research Committee Chair, Dr. Larry Seymour made a major announcement at our Fall Fundraiser in Minneapolis of the 2017 awarding of $65,000 in new sarcoma research grants to Children’s Hospitals and Clinics of Minnesota, the Mayo Clinic and SARC in Michigan. The evening also included a new commitment to…
The awarded research grants for 2017 are as follows: Engaging the immune system as a strategy for sarcoma therapy Principal Investigator: Antonella Borgatti, DVM, MS Associate Professor, Department of Veterinary Clinical Sciences College of Veterinary Medicine and Masonic Cancer Center Co-Investigator: Daniel Vallera, PhD, Professor, Radiation Oncology, School of Medicine and Masonic Cancer Center Grant:…
